accountATLANTA -(Dow Jones)- Physicians at a major heart conference were surprised Monday by news Boston Scientific Corp. (BSX) suspended implantable defibrillators shipments because of paperwork problems, another hit to the company's already fragile...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Boston Scientific Faces Sales Hit, But Image Another Issue
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account